Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma
Tae Hyun Kim, Joong-Won Park, Yeon-Joo Kim, Bo Hyun Kim, Sang Myung Woo, Sung Ho Moon, Sang Soo Kim, Young-Hwan Koh, Woo Jin Lee, Sang Jae Park, Joo-Young Kim, Dae Yong Kim, Chang-Min Kim
Cancer Res Treat. 2015;47(1):34-45.   Published online 2014 Sep 11     DOI: https://doi.org/10.4143/crt.2013.218
Citations to this article as recorded by Crossref logo
lncRNA MIR22HG-Derived miR-22-5p Enhances the Radiosensitivity of Hepatocellular Carcinoma by Increasing Histone Acetylation Through the Inhibition of HDAC2 Activity
Qiao Jin, Hao Hu, Siqi Yan, Long Jin, Yuliang Pan, Xiangjun Li, Yayi Peng, Peiguo Cao
Frontiers in Oncology.2021;[Epub]     CrossRef
External Beam Radiotherapy for Hepatocellular Carcinoma: a Review of the Current Guidelines in the East and the West
Sang Min Yoon
Journal of Liver Cancer.2021; 21(1): 25.     CrossRef
A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy
Won Il Jang, Sun Hyun Bae, Mi‐Sook Kim, Chul Ju Han, Su Cheol Park, Sang Bum Kim, Eung‐Ho Cho, Chul Won Choi, Kyung Su Kim, Sangyoun Hwang, Jin Ho Kim, A Ram Chang, Younghee Park, Eun Seog Kim, Woo Chul Kim, Sunmi Jo, Hae Jin Park
Cancer.2020; 126(2): 363.     CrossRef
Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
Tae Hyun Kim, Joong-Won Park, Bo Hyun Kim, Eun Sang Oh, Sang Hee Youn, Sung Ho Moon, Sang Soo Kim, Sang Myung Woo, Young-Hwan Koh, Woo Jin Lee, Dae Yong Kim
Frontiers in Oncology.2020;[Epub]     CrossRef
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase trial
Tae Hyun Kim, Young Hwan Koh, Bo Hyun Kim, Min Ju Kim, Ju Hee Lee, Boram Park, Joong-Won Park
Journal of Hepatology.2020;[Epub]     CrossRef
Efficacy and feasibility of proton beam radiotherapy using the simultaneous integrated boost technique for locally advanced pancreatic cancer
Tae Hyun Kim, Woo Jin Lee, Sang Myung Woo, Eun Sang Oh, Sang Hee Youn, Hye Young Jang, Sung-Sik Han, Sang-Jae Park, Yang-Gun Suh, Sung Ho Moon, Sang Soo Kim, Dae Yong Kim
Scientific Reports.2020;[Epub]     CrossRef
A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger
Kei Shibuya, Tatsuya Ohno, Hiroyuki Katoh, Masahiko Okamoto, Shintaro Shiba, Yoshinori Koyama, Satoru Kakizaki, Ken Shirabe, Takashi Nakano
Radiotherapy and Oncology.2019; 132: 230.     CrossRef
Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma?
Tae Kim, Joong-Won Park, Bo Kim, Hyunjung Kim, Sung Moon, Sang Kim, Sang Woo, Young-Hwan Koh, Woo Lee, Dae Kim, Chang-Min Kim
Cancers.2019; 11(2): 230.     CrossRef
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
KLCA Korean Liver Cancer Association, NCC National Cancer Center
Gut and Liver.2019; 13(3): 227.     CrossRef
Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing Outcomes
Mutlay Sayan, Nikhil Yegya-Raman, Stephanie H. Greco, Bin Gui, Andrew Zhang, Anupama Chundury, Miral S. Grandhi, Howard S. Hochster, Timothy J. Kennedy, Russell C. Langan, Usha Malhotra, Vinod K. Rustgi, Mihir M. Shah, Kristen R. Spencer, Darren R. Carpiz
Frontiers in Oncology.2019;[Epub]     CrossRef
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Korean Journal of Radiology.2019; 20(7): 1042.     CrossRef
Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness
Che-Yu Hsu, Chun-Wei Wang, Ann-Lii Cheng, Sung-Hsin Kuo
World Journal of Gastrointestinal Oncology.2019; 11(8): 579.     CrossRef
Proton therapy: the current status of the clinical evidences
Dongryul Oh
Precision and Future Medicine.2019; 3(3): 91.     CrossRef
A systematic review of publications on charged particle therapy for hepatocellular carcinoma
Hiroshi Igaki, Masashi Mizumoto, Toshiyuki Okumura, Kiyoshi Hasegawa, Norihiro Kokudo, Hideyuki Sakurai
International Journal of Clinical Oncology.2018; 23(3): 423.     CrossRef
Strategic application of radiotherapy for hepatocellular carcinoma
Seo Hee Choi, Jinsil Seong
Clinical and Molecular Hepatology.2018; 24(2): 114.     CrossRef
Effectiveness and Safety of Simultaneous Integrated Boost-Proton Beam Therapy for Localized Pancreatic Cancer
Tae Hyun Kim, Woo Jin Lee, Sang Myung Woo, Hyunjung Kim, Eun Sang Oh, Ju Hee Lee, Sung-Sik Han, Sang-Jae Park, Yang-Gun Suh, Sung Ho Moon, Sang Soo Kim, Dae Yong Kim
Technology in Cancer Research & Treatment.2018; 17: 153303381878387.     CrossRef
Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives
Gyu Sang Yoo, Jeong Il Yu, Hee Chul Park
World Journal of Gastroenterology.2018; 24(28): 3090.     CrossRef
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies
Stephanie K. Schaub, Pehr E. Hartvigson, Michael I. Lock, Morten Høyer, Thomas B. Brunner, Higinia R. Cardenes, Laura A. Dawson, Edward Y. Kim, Nina A. Mayr, Simon S. Lo, Smith Apisarnthanarax
Technology in Cancer Research & Treatment.2018; 17: 153303381879021.     CrossRef
Strahlentherapie bei hepatozellulärem Karzinom
Thomas B. Brunner, Eleni Gkika, Christoph Willich, Maciej Pech, Peter Hass
Der Onkologe.2018; 24(9): 698.     CrossRef
Proton Beam Therapy and Carbon Ion Radiotherapy for Hepatocellular Carcinoma
Smith Apisarnthanarax, Stephen R. Bowen, Stephanie E. Combs
Seminars in Radiation Oncology.2018; 28(4): 309.     CrossRef
Proton beam therapy for cancer in the era of precision medicine
Man Hu, Liyang Jiang, Xiangli Cui, Jianguang Zhang, Jinming Yu
Journal of Hematology & Oncology.2018;[Epub]     CrossRef
Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma
Tae Hyun Kim, Joong-Won Park, Bo Hyun Kim, Dae Yong Kim, Sung Ho Moon, Sang Soo Kim, Ju Hee Lee, Sang Myung Woo, Young-Hwan Koh, Woo Jin Lee, Chang-Min Kim
Oncotarget.2018; 9(3): 4034.     CrossRef
Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis
Dae Yong Kim, Joong-Won Park, Tae Hyun Kim, Bo Hyun Kim, Sung Ho Moon, Sang Soo Kim, Sang Myung Woo, Young-Hwan Koh, Woo Jin Lee, Chang-Min Kim
Radiotherapy and Oncology.2017; 122(1): 122.     CrossRef
Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma
Kuniaki Fukuda, Toshiyuki Okumura, Masato Abei, Nobuyoshi Fukumitsu, Kazunori Ishige, Masashi Mizumoto, Naoyuki Hasegawa, Haruko Numajiri, Kayoko Ohnishi, Hitoshi Ishikawa, Koji Tsuboi, Hideyuki Sakurai, Ichinosuke Hyodo
Cancer Science.2017; 108(3): 497.     CrossRef
Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism
Li Yu, Yifan Sun, Jingjing Li, Yan Wang, Yuxing Zhu, Yong Shi, Xiaojun Fan, Jianda Zhou, Ying Bao, Jie Xiao, Ke Cao, Peiguo Cao
Journal of Experimental & Clinical Cancer Research.2017;[Epub]     CrossRef
Proton beam therapy for hepatocellular carcinoma
Rosanna H Yeung, Tobias R Chapman, Stephen R Bowen, Smith Apisarnthanarax
Expert Review of Anticancer Therapy.2017; 17(10): 911.     CrossRef
Strategies to tackle the challenges of external beam radiotherapy for liver tumors
Michael I Lock, Jonathan Klein, Hans T Chung, Joseph M Herman, Edward Y Kim, William Small, Nina A Mayr, Simon S Lo
World Journal of Hepatology.2017; 9(14): 645.     CrossRef
External beam radiotherapy for unresectable hepatocellular carcinoma
Omar Abdel-Rahman, Zeinab Elsayed
Cochrane Database of Systematic Reviews.2017;[Epub]     CrossRef
Prognostic group stratification and nomogram for predicting overall survival in patients who received radiotherapy for abdominal lymph node metastasis from hepatocellular carcinoma: a multi-institutional retrospective study (KROG 15-02)
Youngkyong Kim, Hee Chul Park, Sang Min Yoon, Tae Hyun Kim, Jieun Lee, Jinhyun Choi, Jeong Il Yu, Jin-Hong Park, Jong Hoon Kim, Joong-Won Park, Jinsil Seong
Oncotarget.2017; 8(55): 94450.     CrossRef
Proton Beam Therapy for Hepatocellular Carcinoma: A Review of the University of Tsukuba Experience
Masashi Mizumoto, Yoshiko Oshiro, Toshiyuki Okumura, Nobuyoshi Fukumitsu, Haruko Numajiri, Kayoko Ohnishi, Teruhito Aihara, Hitoshi Ishikawa, Koji Tsuboi, Hideyuki Sakurai
International Journal of Particle Therapy.2016; 2(4): 570.     CrossRef
Proton Therapy Results in the Treatment of Hepatocellular Carcinoma According to the Barcelona-Clinic Liver Cancer (BCLC) Staging System
Francesco Dionisi, Maurizio Amichetti
International Journal of Medical Physics, Clinical Engineering and Radiation Oncology.2015; 04(02): 96.     CrossRef
Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinoma
Doo Yeul Lee, Joong-Won Park, Tae Hyun Kim, Ju Hee Lee, Bo Hyun Kim, Sang Myung Woo, Sang Soo Kim, Woo Jin Lee, Dae Yong Kim, Chang-Min Kim
Strahlentherapie und Onkologie.2015; 191(11): 835.     CrossRef